Hepcinat Plus(Sofosbuvir and Daclatasvir)Natco Pharma Launched Hepatitis c medicine from bse plus india Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Natco Pharma today said it has launched a fixed-dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat Plus (Hepcinat Plus Tablets), in India.nnThe product is a generic fixed-dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg tablets, used for the treatment of patients with chronic Hepatitis C virus (HCV) infection, it said in a filing to BSE.nnThe company has launched the drug at a maximum retail price of Rs 17,500 for a bottle
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)